Danaher Corporation (0R2B)
LSE
Closed
Aug 25, 2026
Day's Range
212.9552 wk Range
159.95Overview - 0R2B - Danaher Corporation
Key Statistics
Valuation
Enterprise Value
177.18B
P/E (Trailing)
‪0.25‬
Price / Book
‪2.89‬
EV / EBITDA
‪22.07‬
Profitability
Profit Margin
‪15.94%‬
Operating Margin
‪19.77%‬
Return on Assets
‪3.94%‬
Return on Equity
‪7.60%‬
Ownership
Shares Outstanding
700.90M
Float
625.83M
Held by Insiders
‪10.96%‬
Held by Institutions
‪84.50%‬
Price stats
Beta
‪0.79‬
50-Day Avg
‪242.48‬
200-Day Avg
‪235.35‬
Dividends
Frequency
Quarterly
Market Cap - 0R2B - Danaher Corporation
Peers - 0R2B - Danaher Corporation
Peer Comparison
Compared with companies in Diagnostics & Research listed on LSE.
- 0R2BLSEDanaher Corporation153.21BMarket Cap+4.51%52-week change0.25P/E (Trailing)‪15.94%‬Profit Margin
- SHCLSEShaftesbury Capital PLC276.26BMarket Cap+2.32%52-week change7.19P/E (Trailing)‪156.72%‬Profit Margin
- MTOLSEMitie Group plc258.82BMarket Cap+31.15%52-week change34.67P/E (Trailing)‪1.47%‬Profit Margin
- 0R0HLSEThermo Fisher Scientific Inc.251.87BMarket Cap+21.44%52-week change0.33P/E (Trailing)‪15.03%‬Profit Margin
- 0JDMLSEIQVIA Holdings Inc.52.26BMarket Cap+27.26%52-week change0.47P/E (Trailing)‪8.09%‬Profit Margin
- 0HAVLSEAgilent Technologies Inc.50.96BMarket Cap+25.38%52-week change0.39P/E (Trailing)‪19.55%‬Profit Margin
- 0J8PLSEIDEXX Laboratories, Inc.47.84BMarket Cap-15.85%52-week change0.65P/E (Trailing)‪25.03%‬Profit Margin
Profile Summary - 0R2B - Danaher Corporation
About
Danaher Corporation is a leading science and technology company that designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. It operates primarily through three key segments: Biotechnology, which provides tools and services for bioprocessing, genomics, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
